(Q38267378)

1 September 2017

1 reference

title

Immunoradiotherapy for primary nonresectable hepatocellular carcinoma (English)

1 reference

1 September 2017

Sitzmann JV

1

1 reference

PubMed ID

2538937

1 September 2017

Order SE

series ordinal

2

1 reference

1 September 2017

1 April 1989

1 reference

Surgical Clinics of North America

1 September 2017

1 reference

1 September 2017

69

1 reference

1 September 2017

2

1 reference

1 September 2017

393-400

1 reference

The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay

1 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Computed tomography assisted volumetric analysis of primary liver tumor as a measure of response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Primary liver cancer: A review of 205 cases in Hawaii

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

An enzymic method for the trace iodination of immunoglobulins and other proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

A method of trace iodination of proteins for immunologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Radiolabeled antibody in the treatment of primary and metastatic liver malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

90Yttrium antiferritin--a new therapeutic radiolabeled antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Comparison of Ferritins from Neoplastic and Non-Neoplastic Human Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Variables affecting the tumor localization of 131I-antiferritin in experimental hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2944794-8

7 January 2021

10.1016/S0039-6109(16)44794-8

Identifiers

DOI

0 references

PubMed ID

2538937

1 reference

PubMed ID

2538937